Copyright
©2014 Baishideng Publishing Group Inc.
World J Gastroenterol. Sep 28, 2014; 20(36): 12883-12891
Published online Sep 28, 2014. doi: 10.3748/wjg.v20.i36.12883
Published online Sep 28, 2014. doi: 10.3748/wjg.v20.i36.12883
Table 1 Short-term results of gastric cancer surgery with D2 lymphadenectomy in Eastern Asia vs Europe, in clinical trials vs observational studies[16]
| Post-operative mortality | Post-operative morbidity | Median nodes retrieved | Adequate staging (≥15 nodes) | |
| Eastern Asia | ||||
| Trials | 0%-0.8% | 17%-21% | 54 | 100% |
| Observational | < 2% | - | - | - |
| Europe | ||||
| Trials | 5%-14% | 43%-46% | 17 | - |
| Observational | 2%-5% | 21%-35% | 25-26 | 86%-95% |
| IRGGC (VR, SI, PD) | 3.6% | 33.6% | 29 (IQ 21-38) | 93.8% |
- Citation: Verlato G, Giacopuzzi S, Bencivenga M, Morgagni P, Manzoni GD. Problems faced by evidence-based medicine in evaluating lymphadenectomy for gastric cancer. World J Gastroenterol 2014; 20(36): 12883-12891
- URL: https://www.wjgnet.com/1007-9327/full/v20/i36/12883.htm
- DOI: https://dx.doi.org/10.3748/wjg.v20.i36.12883